Kistefos
Kistefos A.S. is a privately owned investment firm based in Oslo, Norway, established in 1989. The firm specializes in both fund of funds and direct investments, focusing on early-stage ventures, growth capital, rescue financing, and buyouts. Kistefos targets investments ranging from NOK 10 million to over NOK 100 million, aiming for significant ownership stakes across diverse sectors such as offshore, shipping, banking, financial services, real estate, information technology, and telecommunications. The firm's investment strategy is opportunistic, allowing it to engage with companies at various life-cycle stages and geographies. Kistefos actively collaborates with management teams and founders, providing substantial resources to foster long-term value creation. Investments are typically exited within a three to seven-year timeframe.
Bilagos AS, founded in 2015 and headquartered in Kristiansand, Norway, specializes in SEMINE, an advanced accounting automation software that leverages artificial intelligence and robotics for the digitalization of accounting processes. The software employs machine learning and deep learning techniques to analyze invoice contents, offering insights and suggestions for accounting entries. With a dedicated research and development center in southern Norway and a sales office in Oslo, the company has expanded its operations to include subsidiaries in Kerala and Bengaluru, India. SEMINE has gained recognition as one of the fastest-growing startups in the Nordic region, securing significant investment and partnerships with major corporations, including Microsoft, Sopria Steria, and KPMG Digital. The platform aims to enhance automation and real-time reporting in accounting, moving away from traditional retrospective methods. As of its commercial launch, the company has successfully onboarded numerous well-known brands, highlighting its potential to revolutionize accounting practices for its clients.
Bilagos AS, founded in 2015 and headquartered in Kristiansand, Norway, specializes in SEMINE, an advanced accounting automation software that leverages artificial intelligence and robotics for the digitalization of accounting processes. The software employs machine learning and deep learning techniques to analyze invoice contents, offering insights and suggestions for accounting entries. With a dedicated research and development center in southern Norway and a sales office in Oslo, the company has expanded its operations to include subsidiaries in Kerala and Bengaluru, India. SEMINE has gained recognition as one of the fastest-growing startups in the Nordic region, securing significant investment and partnerships with major corporations, including Microsoft, Sopria Steria, and KPMG Digital. The platform aims to enhance automation and real-time reporting in accounting, moving away from traditional retrospective methods. As of its commercial launch, the company has successfully onboarded numerous well-known brands, highlighting its potential to revolutionize accounting practices for its clients.
Bilagos AS, founded in 2015 and headquartered in Kristiansand, Norway, specializes in SEMINE, an advanced accounting automation software that leverages artificial intelligence and robotics for the digitalization of accounting processes. The software employs machine learning and deep learning techniques to analyze invoice contents, offering insights and suggestions for accounting entries. With a dedicated research and development center in southern Norway and a sales office in Oslo, the company has expanded its operations to include subsidiaries in Kerala and Bengaluru, India. SEMINE has gained recognition as one of the fastest-growing startups in the Nordic region, securing significant investment and partnerships with major corporations, including Microsoft, Sopria Steria, and KPMG Digital. The platform aims to enhance automation and real-time reporting in accounting, moving away from traditional retrospective methods. As of its commercial launch, the company has successfully onboarded numerous well-known brands, highlighting its potential to revolutionize accounting practices for its clients.
Bilagos AS, founded in 2015 and headquartered in Kristiansand, Norway, specializes in SEMINE, an advanced accounting automation software that leverages artificial intelligence and robotics for the digitalization of accounting processes. The software employs machine learning and deep learning techniques to analyze invoice contents, offering insights and suggestions for accounting entries. With a dedicated research and development center in southern Norway and a sales office in Oslo, the company has expanded its operations to include subsidiaries in Kerala and Bengaluru, India. SEMINE has gained recognition as one of the fastest-growing startups in the Nordic region, securing significant investment and partnerships with major corporations, including Microsoft, Sopria Steria, and KPMG Digital. The platform aims to enhance automation and real-time reporting in accounting, moving away from traditional retrospective methods. As of its commercial launch, the company has successfully onboarded numerous well-known brands, highlighting its potential to revolutionize accounting practices for its clients.
Bilagos AS, founded in 2015 and headquartered in Kristiansand, Norway, specializes in SEMINE, an advanced accounting automation software that leverages artificial intelligence and robotics for the digitalization of accounting processes. The software employs machine learning and deep learning techniques to analyze invoice contents, offering insights and suggestions for accounting entries. With a dedicated research and development center in southern Norway and a sales office in Oslo, the company has expanded its operations to include subsidiaries in Kerala and Bengaluru, India. SEMINE has gained recognition as one of the fastest-growing startups in the Nordic region, securing significant investment and partnerships with major corporations, including Microsoft, Sopria Steria, and KPMG Digital. The platform aims to enhance automation and real-time reporting in accounting, moving away from traditional retrospective methods. As of its commercial launch, the company has successfully onboarded numerous well-known brands, highlighting its potential to revolutionize accounting practices for its clients.
Kappa Bioscience AS develops and produces vitamin K2 as menaquinone-7. The company develops vitamin K2 for the food supplement and the fortified food market. It offers K2VITAL, a vitamin K2 product; microencapsulated DELTA for stability in mineral formulations; K2VITAL, MK-7 for food supplement and fortified food application; and MCC powder, MCT oil, DEX powder, and SF oil products. The company offers its products to food supplement and fortified food business manufacturers. It provides its products through distributor in Norway and the United States. Kappa Bioscience AS was founded in 2006 and is based in Oslo, Norway.
Promon AS, founded in 2006 and based in Oslo, Norway, specializes in developing and selling security software designed for businesses that manage sensitive information. The company offers a suite of application security solutions, providing integrated service protection products for online service providers to safeguard web services such as online banking, CRM/ERP systems, public services, and e-commerce platforms. Additionally, Promon delivers integrated application protection products to various software application providers, ensuring the security of sensitive data and maintaining application integrity across a range of sectors, including banking, ERP/CRM systems, gaming, and communication software.
OstomyCure AS is a Medical Technology company with a headquarter in Oslo, Norway. The company develops a revolutionary technology called Transcutaneous Implant Evacuation System, The TIES® System. The TIES® Continent Ileostomy System, is a titanium implant solution with a lid intended to replace a conventional ileostomy. It allows a more carefree life for patients who suffer from inflammatory bowel diseases such as Crohn´s disease, Ulcerative colitis, multiple cancer or other related diseases that need the removal of the colon (large intestine). The TIES® System is the result of several years of research combined with the latest 3D manufacturing technology, developed and produced in accordance with regulatory standards to ensure safety for the patients.